Valstar OverviewValrubicin (N-trifluoroacetyladriamycin-14-valerate, trade name Valstar) is a chemotherapy drug used to treat bladder cancer. Valrubicin is a semisynthetic analog of the anthracycline doxorubicin, and is administered by infusion directly into the bladder. It was originally launched as Valstar in the U.S. in 1999 for intravesical therapy of Bacille Calmette-Guérin (BCG)-refractory carcinoma in situ of the urinary bladder in patients in whom cystectomy would be associated with unacceptable...
Read more Valstar Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Valrubicin
Recent Valstar Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Solution: 40mg/ml
NDC Database Records for Valstar: (1 result)Sorted by National Drug Code
- 67979-001 Valstar 40 mg/ml Intravesical Solution, Concentrate by Endo Pharmaceuticals Solutions Inc.